Cargando…
Effect of adjuvant bisphosphonates on disease-free survival in early breast cancer: Retrospective analysis results in an unselected single-center cohort
Bisphosphonates are the gold standard for preventing skeletal-related events in patients with bone-metastatic cancer and have been investigated for reducing cancer treatment-induced bone loss. Evidence suggests bisphosphonates also offer anticancer benefits in adjuvant and advanced cancer settings....
Autores principales: | Hadji, Peyman, Frank, Matthias, Jakob, Andreas, Siebers, Jan Willem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723356/ https://www.ncbi.nlm.nih.gov/pubmed/26909267 http://dx.doi.org/10.1016/j.jbo.2013.01.001 |
Ejemplares similares
-
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009) -
Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results
por: Diel, I J, et al.
Publicado: (2000) -
Survival rates and prognostic factors in right- and left-sided colon cancer stage I–IV: an unselected retrospective single-center trial
por: Degro, Claudius E., et al.
Publicado: (2021) -
Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010) -
Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)